Gut Microbiome Changes in Patients with Active Left-sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy

by Dagmar Schierová, Jan Březina, Jakub Mrázek, Kateřina Olša Fliegerová, Simona Kvasnová, Lukáš Bajer, Pavel Drastich
Published 2020-10-01

Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response

by Stepan Coufal, Natalie Galanova, Lukas Bajer, Zuzana Gajdarova, Dagmar Schierova, Zuzana Jiraskova Zakostelska, Klara Kostovcikova, Zuzana Jackova, Zuzana Stehlikova, Pavel Drastich, Helena Tlaskalova-Hogenova, Miloslav Kverka
Published 2019-07-01

Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial

by Jan Březina, Lukáš Bajer, Pavel Wohl, Dana Ďuricová, Pavel Hrabák, Aleš Novotný, Jana Koželuhová, Milan Lukáš, Jakub Mrázek, Kateřina Olša Fliegerová, Simona Kvasnová, Mekadim Chahrazed, Jan Mareš, Julius Špičák, Pavel Drastich
Published 2021-06-01